In vitro susceptibility of isolates of Scytalidium spp. from superficial lesions against posaconazole;Étude in vitro de la sensibilité au posaconazole de souches de Scytalidium spp. isolées de lésions superficielles

Pathologie Biologie

Volumn 56, Issue 5, 2008, Pages 268-271

  Dunand, J ^a   Paugam, A ^b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b hôpital Cochin ^*  (France)

Author keywords

Minimum inhibitory concentration (MIC); Posaconazole; Scytalidium

Indexed keywords

POSACONAZOLE; ANTIFUNGAL AGENT; TRIAZOLE DERIVATIVE;

ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DERMATOPHYTE; DRUG EFFICACY; FUNGUS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCYTALIDIUM DIMIDIATUM; SCYTALIDIUM HYALINUM; ANTIFUNGAL RESISTANCE; ASCOMYCETES; COMPARATIVE STUDY; DERMATOMYCOSIS; DEUTEROMYCETES; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; ONYCHOMYCOSIS; SKIN DISEASE;

ANTIFUNGAL AGENTS; ASCOMYCOTA; DERMATOMYCOSES; DRUG RESISTANCE, FUNGAL; FOOT DERMATOSES; HUMANS; MICROBIAL SENSITIVITY TESTS; MITOSPORIC FUNGI; ONYCHOMYCOSIS; TRIAZOLES;

EID: 47049092987     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2007.12.006     Document Type: Article

References (28)

1. Soler C.P., Gerome P., Leguyadec T., Hance P., Nizou J.Y., and Le Vagueresse R. Scytalidium dimidiatum pseudodermatophyte, agent of superficial mycoses and phaehyphomycosis. Med Trop 59 (1999) 375-377
2. Levi M.E., and Smith J.W. Posttraumatic infection due to Scytalidium dimidiatum. Clin Infect Dis 18 (1994) 127-128
3. Hay R.J., and Moore M.K. Clinical features of superficial fungal infections caused by Hendersonula toruloidea and Scytalidium hyalinum. Br J Dermatol 110 (1984) 677-683
4. Maslin J., and Morand J.J. Scytalidium infections. Med Trop 62 (2002) 132-134
5. Godoy P., Reyes E., Silva V., Nunes F., Tomimori-Yamashita J., Zaror L., et al. Dermatomycoses caused by Nattrassia mangiferae in Sao Paulo, Brazil. Mycopathologia 157 (2004) 273-276
6. Lacroix C., Kac G., Dubertret L., Morel P., Derouin F., and de Chauvin M.F. Scytalidiosis in Paris, France. J Am Acad Dermatol 48 (2003) 852-856
7. Morris-Jones R., Youngchim S., Hextall J.M., Gomez B.L., Morris-Jones S.D., Hay R.J., et al. Scytalidium dimidiatum causing recalcitrant subcutaneous lesions produces melanin. J Clin Microbiol 42 (2004) 3789-3794
8. Elewski B.E. Onychomycosis caused by Scytalidium dimidiatum. J Am Acad Dermatol 35 (1996) 336-338
9. Paugam A. The latest data on posaconazole. Med Mal Infect 37 (2007) 71-76
10. Pfaller M.A., Messer S.A., Mills K., and Bolmstrom A. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol 38 (2000) 3359-3361
11. Guinea J., Pelaez T., Alcala L., and Bouza E. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis 57 (2007) 273-276
12. Pfaller M.A., Messer S.A., Boyken L., Hollis R.J., and Diekema D.J. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs. Diagn Microbiol Infect Dis 45 (2003) 241-244
13. Cuenca-Estrella M., Gomez-Lopez A., Mellado E., Buitrago M.J., Monzon A., and Rodriguez-Tudela J.L. Head-to-head comparison of the activities of currently available antifungal agents against 3378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 50 (2006) 917-921
14. Barchiesi F., Arzeni D., Camiletti V., Simonetti O., Cellini A., Offidani A.M., et al. In vitro activity of posaconazole against clinical isolates of dermatophytes. J Clin Microbiol 39 (2001) 4208-4209
15. Ghannoum M.A., Arthington-Skaggs B., Chaturvedi V., Espinel-Ingroff A., Pfaller M.A., Rennie R., et al. Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals. J Clin Microbiol 44 (2006) 4353-4356
16. Gupta A.K., Kohli Y., and Batra R. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Med Mycol 43 (2005) 179-185
17. Ezzet F., Wexler D., Courtney R., Krishna G., Lim J., and Laughlin M. Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations. Clin Pharmacokinet 44 (2005) 211-220
18. Cuenca-Estrella M., Gomez-Lopez A., Buitrago M.J., Mellado E., Garcia-Effron G., and Rodriguez-Tudela J.L. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother 50 (2006) 2248-2250
19. Negroni R., Tobon A., Bustamante B., Shikanai-Yasuda M.A., Patino H., and Restrepo A. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47 (2005) 339-346
20. Haneke E., and Roseeuw D. The scope of onychomycosis: epidemiology and clinical features. Int J Dermatol 38 (1999) 7-12
21. Belloeuf L., Boisseau-Garsaud A.M., Saint-Cyr I., Desbois N., Helenon R., Queneherve C., et al. Nail disease due to Scytalidium in Martinique (French West Indies)]. Ann Dermatol Venereol 131 (2004) 245-249
22. Ungpakorn R. Mycoses in Thailand: current concerns. Nippon Ishinkin Gakkai Zasshi 46 (2005) 81-86
23. Barua P., Barua S., Borkakoty B., and Mahanta J. Onychomycosis by Scytalidium dimidiatum in green tea leaf pluckers: report of two cases. Mycopathologia 164 (2007) 193-195
24. De Doncker P. Pharmacokinetics of orally administered antifungals in onychomycosis. Int J Dermatol 38 (1999) 20-27
25. Kotrajaras R., Chongsathien S., Rojanavanich V., Buddhavudhikrai P., and Viriyayudhakorn S. Hendersonula toruloidea infection in Thailand. Int J Dermatol 27 (1988) 391-395
26. Obasi O.E., and Clayton Y.M. Dermatophyte fungi in the Guinea Savannah region of Nigeria and the changing phase of dermatophytosis in Nigeria. Mycoses 32 (1989) 381-385
27. Kombila M., Martz M., Gomez de Diaz M., de Bievre C., and Richard-Lenoble D. Hendersonula toruloidea as an agent of mycotic foot infection in Gabon. J Med Vet Mycol 28 (1990) 215-223
28. Allison V.Y., Hay R.J., and Campbell C.K. Hendersonula toruloidea and Scytalidium hyalinum infections in Tobago. Br J Dermatol 111 (1984) 371-372